Project profile — CHVI - Sustainable Regulatory Development to Accelerate Access to HIV Vaccines
Overview
Overview
| CA-3-M013028001 | |
| $2,000,000 | |
| WHO - World Health Organization (XM-DAC-41143) | |
| 2010-01-14 - 2013-03-31 | |
| Closed |
Country / region
• Africa, regional (100.00%)Sector
• Population Policies/Programmes And Reproductive HealthSTD control including HIV/AIDS (13040) (100.00%)
Policy marker
• Gender equality (not targeted)• Environmental sustainability (cross-cutting) (not targeted)
• Participatory development and good governance (not targeted)
• Trade development (not targeted)
• Biodiversity (not targeted)
• Climate change mitigation (not targeted)
• Climate Change Adaptation (not targeted)
• Urban issues (not targeted)
• Desertification (not targeted)
• Children's issues (not targeted)
• Youth Issues (not targeted)
• Indigenous Issues (not targeted)
• Disability (not targeted)
• ICT as a tool for development (not targeted)
Description and results
Description
The goal of this program under the Policy and Regulatory Issues component of Canadian HIV Vaccine Initiative (CHVI) is to support activities to improve regulatory capacity in low- and middle-income countries, especially those where clinical trials are planned or ongoing. The program supports the integration of ethical review, regulation, and registration of clinical trials in Africa. It promotes and strengthens the collaboration between ethical committees and regulatory authorities in the targeted African countries. Finally, it develops training material, including e-learning tools for national regulatory authorities and ethics committees.
Results achieved
Results achieved as of June 2013 include: The African Vaccine Regulatory Forum (AVAREF) was formalized and courses on the inspection of good clinical practices as well as on the evaluation of clinical data were provided in the 19 AVAREF member countries. A course on legislation was developed to support national review authorities in the development of the legal framework for clinical trials. This course was delivered to 17 participants representing ten low and middle-income countries. The project also strengthened monitoring practices through the development of indicators that support research ethical committees and research institutions in low and middle-income countries to meet international ethics standards when conducting research with human participants.
Financials
Financials
|
|||||||||||||||
Related information
Related information
|
Related links • Partner website — WHO - World Health Organization |
|
| Global Affairs Canada | |
| MFM Global Issues & Dev.Branch | |
| Aid grant excluding debt reorganisation | |
| Bilateral | |
| Contributions to specific-purpose programmes and funds managed by implementing partners |
Legend
The coloured circles represent the number of markers in proximity. Simply click on the circle to zoom in for more information on projects.
2 to 9 markers
10 to 99 markers
100 to 999 markers
1,000 to 9,999 markers
Marker
Note: The Project Browser provides access to project data published by Global Affairs Canada in accordance with the International Aid Transparency Initiative (IATI) standard. This is not meant for official reporting, but to provide information on past and current international projects.